2D cell culture involves growing cells on a flat surface called 2D monolayers. This method limits the formation of multi-dimensional cell cultures. In the 3D cell culture method, on the other hand, biological cells are allowed to grow or interact with their surroundings in all three dimensions. This method enables cells to grow in vitro; these surroundings better mimic the in vivo conditions in which the cells are naturally present. The 3D cell culture technique has proven to be very efficient in several studies of basic biological mechanisms such as cell number monitoring, cell viability, cell proliferation, cell morphology, and so on. Moreover, 3D cell cultures have greater stability and longer lifespans compared to 2D cell cultures.
Owing to the benefits offered by the 3D cell culture model, these techniques are being widely adopted in cancer research studies. Cancer cells grown in 2D cell cultures can be easily destroyed by low dosage radiation, while the same cells grown in 3D cell cultures are far more resistant to low radiation doses, thus mimicking an in vivo environment. Therefore, 3D cell culture technique is considered a more practical approach for testing and discovering new drugs to treat cancer.
Apart from the opportunities presented by microfluidics-based 3D cell culture, 3D cell printing is another noteworthy addition to the 3D cell culture market. 3D cell printing uses inkjet-like nozzles to deposit cells into defined structures. The technique uses 3D printing to produce organ models. Several universities and companies, such as BioBots, and Organovo, are working towards the development of 3D-printed organ models.
Scaffold-based 3D cell culture products expected to dominate the market in 2017.
Owing to the benefits offered by the 3D cell culture model, these techniques are being widely adopted in cancer research studies. Cancer cells grown in 2D cell cultures can be easily destroyed by low dosage radiation, while the same cells grown in 3D cell cultures are far more resistant to low radiation doses, thus mimicking an in vivo environment. Therefore, 3D cell culture technique is considered a more practical approach for testing and discovering new drugs to treat cancer.
Apart from the opportunities presented by microfluidics-based 3D cell culture, 3D cell printing is another noteworthy addition to the 3D cell culture market. 3D cell printing uses inkjet-like nozzles to deposit cells into defined structures. The technique uses 3D printing to produce organ models. Several universities and companies, such as BioBots, and Organovo, are working towards the development of 3D-printed organ models.
Scaffold-based 3D cell culture products expected to dominate the market in 2017.
Based on product, the 3D cell culture market is segmented into scaffold-based 3D cell culture, scaffold-free 3D cell culture, microfluidics-based 3D cell culture, and magnetic levitation and 3D bioprinting. In 2017, the scaffold-based 3D cell culture products segment is expected to account for the largest share of the 3D cell culture market. The high growth in this segment is attributed to the ability of scaffold-based products to mimic in vivo conditions, thus driving their adoption among end users.
Comments
Post a Comment